X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4866) 4866
Newsletter (84) 84
Newspaper Article (38) 38
Magazine Article (19) 19
Book Chapter (14) 14
Dissertation (6) 6
Conference Proceeding (4) 4
Book / eBook (3) 3
Reference (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3060) 3060
male (2320) 2320
fructose (2092) 2092
fructose - adverse effects (1927) 1927
female (1777) 1777
fructose - analogs & derivatives (1600) 1600
animals (1527) 1527
adult (1222) 1222
fructose - therapeutic use (1051) 1051
topiramate (1019) 1019
fructose - administration & dosage (879) 879
rats (832) 832
middle aged (829) 829
glucose (822) 822
nutrition & dietetics (701) 701
obesity (700) 700
diet (689) 689
clinical neurology (683) 683
anticonvulsants - adverse effects (678) 678
anticonvulsants - therapeutic use (625) 625
metabolic syndrome (578) 578
insulin resistance (558) 558
adolescent (556) 556
metabolism (488) 488
treatment outcome (488) 488
insulin-resistance (464) 464
risk factors (455) 455
child (436) 436
pharmacology & pharmacy (426) 426
oxidative stress (421) 421
fructose - pharmacology (415) 415
analysis (409) 409
research (404) 404
aged (390) 390
fructose - metabolism (383) 383
physiological aspects (379) 379
epilepsy (376) 376
health aspects (366) 366
mice (362) 362
diabetes (360) 360
liver (358) 358
sucrose (357) 357
liver - metabolism (354) 354
rats, wistar (348) 348
dose-response relationship, drug (346) 346
double-blind (333) 333
neurosciences (329) 329
epilepsy - drug therapy (327) 327
insulin (323) 323
psychiatry (319) 319
dextrose (314) 314
endocrinology & metabolism (308) 308
sugar (298) 298
rodents (296) 296
consumption (291) 291
dietary carbohydrates - adverse effects (287) 287
hypertension (287) 287
young adult (283) 283
rats, sprague-dawley (282) 282
double-blind method (277) 277
beverages (273) 273
biochemistry & molecular biology (273) 273
sugars (253) 253
body weight (250) 250
disease models, animal (247) 247
liver - drug effects (247) 247
inflammation (246) 246
children (242) 242
antiepileptic drugs (236) 236
neurology (234) 234
drug therapy, combination (233) 233
anticonvulsants - administration & dosage (232) 232
blood glucose - metabolism (229) 229
child, preschool (229) 229
insulin - blood (226) 226
nutrition (223) 223
care and treatment (217) 217
proteins (214) 214
fatty liver (211) 211
drug therapy (209) 209
lipids (208) 208
time factors (208) 208
carbohydrates (207) 207
sweetening agents - adverse effects (206) 206
migraine (204) 204
prevention (201) 201
physiology (199) 199
studies (198) 198
dietary sucrose - adverse effects (197) 197
abridged index medicus (196) 196
risk (193) 193
efficacy (190) 190
medicine (189) 189
triglycerides - blood (189) 189
enzymes (188) 188
liver diseases (188) 188
medicine, general & internal (187) 187
gene expression (186) 186
pediatrics (186) 186
food science & technology (185) 185
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4742) 4742
German (124) 124
Spanish (57) 57
Japanese (43) 43
French (38) 38
Russian (32) 32
Portuguese (22) 22
Chinese (15) 15
Italian (12) 12
Swedish (5) 5
Czech (4) 4
Danish (4) 4
Dutch (4) 4
Hungarian (4) 4
Norwegian (4) 4
Polish (3) 3
Romanian (3) 3
Korean (2) 2
Greek (1) 1
Hebrew (1) 1
Thai (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Epilepsy & behavior, ISSN 1525-5050, 2017, Volume 71, Issue Pt A, pp. 73 - 78
... side effects was undertaken in patients with treated epilepsy participating in prospective audits with new antiepileptic drugs (AEDs... 
Neurology | Antiepileptic drug | Side effects | Prospective audit | Epilepsy | Psychiatric | Seizures | DEPRESSION | POPULATION | REFRACTORY EPILEPSY | MENTAL-RETARDATION | PSYCHIATRY | CLINICAL NEUROLOGY | INTELLECTUAL DISABILITY | JUVENILE MYOCLONIC EPILEPSY | BEHAVIORAL SCIENCES | PEOPLE | ANXIETY DISORDERS | FOCAL EPILEPSY | LEVETIRACETAM | Pregabalin - adverse effects | Prospective Studies | Pregabalin - therapeutic use | Humans | Medical Audit - methods | Middle Aged | Piracetam - adverse effects | Seizures - drug therapy | Male | Young Adult | Anticonvulsants - adverse effects | Acetamides - therapeutic use | Piracetam - therapeutic use | Sodium Channel Blockers - adverse effects | Acetamides - adverse effects | Aged, 80 and over | Sodium Channel Blockers - therapeutic use | Adult | Female | Retrospective Studies | Mental Disorders - diagnosis | Epilepsy - psychology | Fructose - adverse effects | Mental Disorders - chemically induced | Dibenzazepines | Anticonvulsants - therapeutic use | Pyridones | Fructose - therapeutic use | Epilepsy - diagnosis | Mental Disorders - psychology | Fructose - analogs & derivatives | Piracetam - analogs & derivatives | Adolescent | Epilepsy - drug therapy | Aged | Drug-Related Side Effects and Adverse Reactions - diagnosis | Drug-Related Side Effects and Adverse Reactions - psychology | Seizures - psychology | Drugs | Complications and side effects | Anticonvulsants | Comorbidity | Learning disabilities | Seizures (Medicine) | Mental illness | Depression, Mental
Journal Article
Seizure: European Journal of Epilepsy, ISSN 1059-1311, 2010, Volume 19, Issue 9, pp. 562 - 566
Journal Article
Journal Article
Toxicology and applied pharmacology, ISSN 0041-008X, 03/2014, Volume 275, Issue 2, pp. 182 - 188
Journal Article
PloS one, ISSN 1932-6203, 2012, Volume 7, Issue 6, p. e38123
Journal Article
American journal of physiology. Heart and circulatory physiology, ISSN 0363-6135, 2017, Volume 312, Issue 2, pp. H289 - H304
High consumption of simple sugars causes adverse cardiometabolic effects. We investigated the mechanisms underlying the metabolic and vascular effects... 
Insulin resistance | Glucose | Liver | Fructose | Adiponectin | TRIGLYCERIDE TRANSFER PROTEIN | adiponectin | glucose | FRUCTOSE-FED RATS | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | ENDOTHELIAL DYSFUNCTION | liver | LIQUID FRUCTOSE | VASCULAR DYSFUNCTION | fructose | HYPERPOLARIZING FACTOR | HEPATIC INSULIN-RESISTANCE | FRUCTOKINASE EXPRESSION | NITRIC-OXIDE | PERIPHERAL VASCULAR DISEASE | ARTIFICIALLY-SWEETENED BEVERAGES | insulin resistance | PPAR alpha - drug effects | Phosphorylation | Aorta - metabolism | Nitroprusside - pharmacology | Carrier Proteins - drug effects | Phenylephrine - pharmacology | Liver - drug effects | Fructose - pharmacology | Carnitine O-Palmitoyltransferase - metabolism | Adiponectin - metabolism | Carnitine O-Palmitoyltransferase - drug effects | Female | Aorta - physiopathology | Nitric Oxide Donors - pharmacology | Nitric Oxide Synthase Type III - metabolism | Real-Time Polymerase Chain Reaction | Bradykinin - pharmacology | Vasoconstrictor Agents - pharmacology | Vasodilator Agents - pharmacology | Dietary Sucrose - pharmacology | Signal Transduction | Acetylcholine - pharmacology | Aorta - drug effects | Liver - metabolism | Rats | Glucose - pharmacology | Energy Intake | Rats, Sprague-Dawley | Blotting, Western | Triglycerides - metabolism | Insulin - metabolism | Animals | Carrier Proteins - metabolism | Lipogenesis - drug effects | Lipid Metabolism - drug effects | PPAR alpha - metabolism | Nitric Oxide Synthase Type III - drug effects | Physiological aspects | Aorta | Health aspects | Sugar | Proteïnes de la sang | Resistència a la insulina | Fetge | Fructosa | Disorders of metabolism | Glucosa | Trastorns del metabolisme | Blood proteins
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2016, Issue 3, p. CD007654
...‐serious adverse events). Secondary objectives: To assess the long‐term effects of pharmacologically induced reduction in body weight in adults with essential... 
Blood Pressure | Topiramate | Appetite Depressants | Anti‐Obesity Agents | Time | Diet, Reducing | Lactones | Cyclobutanes | Piperidines | Orlistat | Safety‐Based Drug Withdrawals | Heart & circulation | Hypertension | Kidney disease | Treatment: pharmacological | Pyrazoles | Phentermine | Pharmacological Therapies | Fructose | Randomized Controlled Trials as Topic | General Pharmacotherapies | Rimonabant | Weight Loss | Medicine General & Introductory Medical Sciences | Treatment of essential Hypertension | REVERSES METABOLIC SYNDROME | Cyclobutanes [adverse effects] | OBSTRUCTIVE SLEEP-APNEA | TOPIRAMATE EXTENDED-RELEASE | Pyrazoles [adverse effects] | CARDIOMETABOLIC RISK-FACTORS | Safety-Based Drug Withdrawals | CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE | LIRAGLUTIDE 3.0 MG | CARDIOVASCULAR-DISEASE RISK | MEDICINE, GENERAL & INTERNAL | Blood Pressure [drug effects] | NALTREXONE SR/BUPROPION SR | Lactones [adverse effects] | Anti-Obesity Agents [adverse effects] | PLACEBO-CONTROLLED TRIAL | Hypertension [drug therapy; mortality] | TYPE-2 DIABETES-MELLITUS | Piperidines [adverse effects] | Pyrazoles - therapeutic use | Appetite Depressants - adverse effects | Humans | Middle Aged | Anti-Obesity Agents - adverse effects | Hypertension - drug therapy | Male | Appetite Depressants - therapeutic use | Anti-Obesity Agents - therapeutic use | Phentermine - adverse effects | Phentermine - therapeutic use | Adult | Female | Blood Pressure - drug effects | Hypertension - mortality | Pyrazoles - adverse effects | Cyclobutanes - adverse effects | Fructose - adverse effects | Cyclobutanes - therapeutic use | Lactones - adverse effects | Fructose - therapeutic use | Lactones - therapeutic use | Fructose - analogs & derivatives | Piperidines - therapeutic use | Piperidines - adverse effects
Journal Article